Structure Therapeutics Inc.’s current stock price and volume Why Structure Therapeutics Inc.’s stock price changed recently Upgrades and downgrades for GPCR from analysts GPCR’s stock price momentum ...

Year to date, shares of VKTX and GPCR have plunged 38.9% and 30.1%, respectively, compared with the industry’s 6.4% decline. Image Source: Zacks Investment Research VKTX is currently evaluating ...

This study provides a methodological report on a modified adaptive sampling approach, multiple walker supervised molecular dynamics (mwSuMD), and its application to G protein-coupled receptors (GPCR), ...

Yup, for real. After months of preparation from chefs Omar Tate and Cybille St. Aude-Tate and their team, it looks like there’s finally an opening date for their long-anticipated new restaurant ...

In the study, Wu and team used a community of 30 bacterial strains commonly found in the human gut. They then added 127 G-protein-coupled receptor (GPCR)-targeting drugs individually to the microbial ...

G protein-coupled receptors (GPCRs) are one of the most desirable and challenging target classes in drug discovery, as their mutation can lead to a wide range of diseases such as cancer, ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. The complement system plays crucial roles in ...

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target ...